LINXIA DONG: Open Payments
NPI 1689915894 · BRIDGEPORT, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,861 in 148 payments from 26 companies in 2025. Trend: 2023 $2,283 · 2024 $2,007 · 2025 $2,861
Food & beverage: $2,861
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 43 | $803 |
| Abbott Laboratories | 15 | $227 |
| Amgen Inc. | 12 | $223 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $166 |
| Insulet Corporation | 8 | $165 |
| Xeris Pharmaceuticals, Inc. | 7 | $156 |
| Lilly USA, LLC | 6 | $135 |
| Novartis Pharmaceuticals Corporation | 5 | $103 |
| Alexion Pharmaceuticals, Inc. | 4 | $94 |
| ABBVIE INC. | 5 | $90 |
Products named: Ozempic, JARDIANCE, FREESTYLE LIBRE 3, Omnipod, EVENITY, GVOKE HYPOPEN, Wegovy, LEQVIO.
Industry payments across WV — which companies pay providers there.
